Key Highlights

  • Ispire reported Revenue of $50.6 million for the six months ended December 31, 2025, down 37.6% year over year, with a net loss of $9.9 million.
  • The December quarter alone saw revenue of $20.3 million, down about 51.5%, amid lower vaping-hardware sales and tighter U.S. Credit terms.
  • Cash declined to $17.6 million and stockholders' Equity swung to a deficit.
  • ISPR shares have cooled amid the sharp deterioration in revenue and the company's financial footing.

Ispire Technology Inc. (NASDAQ:ISPR), a manufacturer of vaping hardware for the nicotine and cannabis markets, has seen its shares cool amid a sharp downturn in its business, with revenue falling and losses widening. For investors weighing whether a rebound is closer than it looks, the latest results are a sobering counterpoint to any optimism, underscoring how much the company must stabilize before a recovery narrative can take hold.

Ispire designs and sells vaporizer devices and technology, serving both regulated cannabis operators and nicotine brands, and has pursued initiatives such as age-verification and precision-dosing technology to differentiate. But the vaping and cannabis hardware space has been buffeted by soft demand, pricing pressure and credit challenges among customers, which have weighed heavily on the company.

Latest developments

For the six months ended December 31, 2025 (its fiscal second quarter of 2026), Ispire reported revenue of $50.6 million, down 37.6% year over year, with a net loss of $9.9 million. The December quarter alone was weaker still, with revenue of $20.3 million down about 51.5%, which management attributed to lower vaping-hardware sales in Europe and North America and tighter credit terms in the U.S.

Gross Margin compressed to roughly 17%, cash declined to $17.6 million, and stockholders' equity swung to a deficit, while credit-loss expenses reflected collection challenges in the sector.

Financial and Business position

The combination of falling revenue, thin margins, a shrinking cash balance and a Negative equity position raises clear questions about Ispire's financial footing and its ability to fund a turnaround without additional capital. The company's exposure to the cannabis and vaping markets, where customers themselves face financing and regulatory pressures, amplifies the risk.

Stock-market context

ISPR shares have cooled amid the deterioration, and despite it, the stock carries a strong-buy rating in the underlying data, a reminder that ratings can lag operating reality in small, volatile names. The rebound case would require Demand and margins to bottom and the Balance Sheet to stabilize; the cautionary case is that the sharp revenue decline, negative equity and credit-loss pressures could persist.

What investors should watch

The decisive signals would be a stabilization and eventual return to revenue growth, improvement in gross margin from the depressed mid-teens level, a rebuilt cash position and equity base, and evidence that credit and collection issues are contained.

Stabilization Before Recovery

The wider context for Ispire is an industry in flux: regulatory scrutiny of vaping products, enforcement actions against unauthorized devices, and financial strain among cannabis operators have combined to pressure demand and tighten credit throughout the hardware Supply chain. Investors should treat the strong-buy rating cautiously and focus on tangible evidence, steadier revenue, firmer margins and a repaired balance sheet, before concluding that the worst is behind the business.